SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a substantial price and volume surge, with community conversations heavily focused on a potential short squeeze driven by a high cost to borrow. Traders are actively anticipating a "supernova" run, drawing comparisons to its past volatile rallies and aiming for significant price levels. This intense action is dominating market discussion for the low-float stock.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending after unveiling its Core Ultra Series 3 processors built on the advanced 18A manufacturing process at CES, sparking renewed optimism for its AI and competitive chip production turnaround. While many in the community are bullish on its innovation and long-term potential, others are skeptical about the stock's ability to hold recent gains amidst fierce competition and historical profit-taking.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to heightened speculation surrounding potential U.S. interest in acquiring Greenland, home to CRML's significant Tanbreez rare earths project. This geopolitical narrative, coupled with CRML's formal announcement of pilot plant construction in Greenland, is driving strong investor enthusiasm. The community is actively discussing the stock's strategic importance for Western rare earth supply chains, anticipating substantial future growth.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending after a recent analyst initiated coverage with a Buy rating, citing its unique position in AI adoption for government and enterprise customers and forecasting significant upside potential. This bullish outlook is contested by some who highlight extreme valuation multiples and concerns around insider selling, while others celebrate potential short squeezes. The intense debate reflects the divergent community perspectives on its growth trajectory amidst broader AI sector enthusiasm.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending amid increasing geopolitical tensions and China's recent export restrictions, which underscore the critical importance of secure domestic supply chains for essential minerals. The community is actively discussing the company's unique position as a vital U.S. military supplier, anticipating significant news regarding ongoing smelter expansions and potential government contracts. Investors remain largely bullish, seeing current movements as opportunities to accumulate given the broader strategic demand for antimony.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics (GLUE) is trending following positive interim Phase 1 data for its MRT-8102 candidate, demonstrating significant reductions in inflammatory markers for cardiovascular disease. This breakthrough, coupled with a major collaboration deal with Novartis for its molecular glue degrader platform, is driving strong bullish sentiment among investors who are discussing a potential short squeeze, while a segment cautions on current valuation.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is generating buzz following its announcement of a successful 3D-printed fuel tank test, a development seen as a key advancement for space transportation. The stock's low float and market cap are fueling community discussions about a potential short squeeze and drawing comparisons to major space and defense industry players. This, coupled with resilience shown after a recent private placement, is driving strong bullish sentiment for future upside.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is currently trending due to recent positive financial developments, a strategic acquisition enhancing its defense technology capabilities, and its inclusion in major market indexes. The community is actively discussing its perceived undervaluation within the burgeoning space sector, with many anticipating significant growth driven by upcoming missions and potential government contracts.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is commanding significant market attention, buoyed by recent analyst upgrades, including several firms naming it a top pick for 2026, and a robust outlook for the energy drink sector. The community is actively discussing strong growth fueled by expanded distribution through its key partner and a strategic share repurchase program. Investors are keenly watching technical breakouts and the potential for a short squeeze, reflecting broad anticipation for continued market share gains.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies is trending amidst volatile trading, sparked by the appointment of Martin Shkreli as a strategic advisor, which has divided investors. While some see Shkreli's involvement as a positive catalyst given his contacts, others worry about his reputation and potential impact on the company's valuation, especially given the company's current lack of revenue and the sector's forward-looking nature.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of -550.00% and +40.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?

Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates

Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

U.S. stocks were on the backfoot on Wednesday as the all-important earnings from Nvidia Corp. (<a class="mention" data-mention="$NVDA" data-symbol-id="NVDA" href="https://stocktwits.com/symbol/NVDA" target="_blank">$NVDA</a>) looms large. Given hyped up expectations, the artificial intelligence stalwart has to issue not merely strong guidance but "insane" guidance that's not yet priced in, said LPLFinancial Chief Global Strategist Quincy Krosby.Ahead of the Nvidia's earnings due after the market close, the following stocks are eliciting most bearish sentiment from the retail crowd:Williams-Sonoma, Inc. (<a class="mention" data-mention="$WSM" data-symbol-id="WSM" href="https://stocktwits.com/symbol/WSM" target="_blank">$WSM</a>)Shares of San Francisco, California-based omni-channel specialty retailer of home products, soared to a record high following a beat-and-raise quarter.&nbsp;Retail largely ignored the positive results and the stock strength and fretted over valuation.&nbsp;<stembedurl>https://stocktwits.com/FetchDog/message/593355051</stembedurl>XP, Inc. (<a class="mention" data-mention="$XP" data-symbol-id="XP" href="https://stocktwits.com/symbol/XP" target="_blank">$XP</a>)&nbsp;XP shares fell over 5% after the Brazilian financial services company reported a double miss for the third quarter. Traders largely ignored a new share repurchase agreement announced by the company.Lineage Cell Therapeutics, Inc. (<a class="mention" data-mention="$LCTX" data-symbol-id="LCTX" href="https://stocktwits.com/symbol/LCTX" target="_blank">$LCTX</a>)Micro-cap clinical-stage biopharma Lineage Cell Therapeutics announced that it entered into definitive agreements with certain healthcare focused institutional investors and with Broadwood Partners, L.P. for raising up to $66 million in a registered direct offering of common stocks and warrants to purchase common stock. The stock was down over 30% at last check.Star Bulk Carriers Corp. (<a class="mention" data-mention="$SBLK" data-symbol-id="SBLK" href="https://stocktwits.com/symbol/SBLK" target="_blank">$SBLK</a>)Greek shipping company Star Bulk Carriers has seen its stock fall over 4.5% as traders digested its mixed earnings report released Tuesday after the close. Incidentally, peer ZIM Integrated Shipping Services Ltd. (<a class="mention" data-mention="$ZIM" data-symbol-id="ZIM" href="https://stocktwits.com/symbol/ZIM" target="_blank">$ZIM</a>) reported a double beat.&nbsp;e.l.f. Beauty, Inc. (<a class="mention" data-mention="$ELF" data-symbol-id="ELF" href="https://stocktwits.com/symbol/ELF" target="_blank">$ELF</a>)Shares of Oakland, California-based e.l.f. Beauty, a maker of cosmetics and skincare products, shed over 9% after short-seller Carson Block's Muddy Waters Research said it is short on the stock.&nbsp;"We believe it's overstating revenue, profits, inventory," the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/muddywatersre/status/1859273379145978200">said</a> in a post on X, adding that about 80% of its products are imported. Import data showed that the company's imports crashes by two-thirds, three quarters ago and haven't recovered since then, it added.The firm sees revenue overstatement to the tune of $135 million-$190 million.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/these-5-stocks-elicited-most-bullish-reactions-from-retail-mid-day-wednesday-novemeber-20/cJ46o5JRXJ"> 5 Stocks Retail Investors Are Most Bullish On At Mid-Day&nbsp;</a>

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

5 Stocks Retail Investors Are Most Bearish On At Mid-Day

Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.

Equity

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Current Price	$1.78
Prev Close	$1.70
Open	$1.72
Dividend Yield	0.00%
50-Day Moving Average	$1.74
Beta	1.11
Avg. Volume	1.29M
PE Ratio	-5.73

52-Week High	$2.09
52-Week Low	$0.3651
Market Capitalization	$391.56M
EPS (Annual)	-$0.093
Price to Book	17.77
Revenue Per Employee	$123,363.64
Enterprise Value/EBITDA	N/A

LCTX
Lineage Cell Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LCTX News

LCTXLineage Cell Therapeutics Inc